These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12966135)

  • 1. Identification of gene expression profile in tolerizing murine cardiac allograft by costimulatory blockade.
    Matsui Y; Saiura A; Sugawara Y; Sata M; Naruse K; Yagita H; Kohro T; Mataki C; Izumi A; Yamaguchi T; Minami T; Sakihama T; Ihara S; Aburatani H; Hamakubo T; Kodama T; Makuuchi M
    Physiol Genomics; 2003 Nov; 15(3):199-208. PubMed ID: 12966135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival.
    Judge TA; Wu Z; Zheng XG; Sharpe AH; Sayegh MH; Turka LA
    J Immunol; 1999 Feb; 162(4):1947-51. PubMed ID: 9973463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice.
    Bashuda H; Seino K; Kano M; Sato K; Azuma M; Yagita H; Okumura K
    Transplant Proc; 1996 Apr; 28(2):1039-41. PubMed ID: 8623220
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of B7 ligands (CD80 and CD86) in CD152-mediated allograft tolerance: a crosscheck hypothesis.
    Tsai MK; Ho HN; Chien HF; Ou-Yang P; Lee CJ; Lee PH
    Transplantation; 2004 Jan; 77(1):48-54. PubMed ID: 14724434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique gene expression profiles of heart allograft rejection in the interferon regulatory factor-1-deficient mouse.
    Erickson L; Crews G; Pan F; Fisniku O; Jang MS; Wynn C; Kobayashi M; Jiang H
    Transpl Immunol; 2004 Nov; 13(3):169-75. PubMed ID: 15381199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance.
    Xie L; Ichimaru N; Morita M; Chen J; Zhu P; Wang J; Urbanellis P; Shalev I; Nagao S; Sugioka A; Zhong L; Nonomura N; Takahara S; Levy GA; Li XK
    Liver Transpl; 2012 Apr; 18(4):444-54. PubMed ID: 22162188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New evidence for a role of allograft accommodation in long-term tolerance.
    Heslan JM; Renaudin K; Thebault P; Josien R; Cuturi MC; Chiffoleau E
    Transplantation; 2006 Nov; 82(9):1185-93. PubMed ID: 17102770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of murine corneal allograft rejection by treatment with antibodies to CD80 and CD86.
    Kagaya F; Hori J; Kamiya K; Kaji Y; Oshika T; Amano S; Yamagami S; Tsuru T; Tanaka S; Matsuda H; Yagita H; Okumura K
    Exp Eye Res; 2002 Jan; 74(1):131-9. PubMed ID: 11878826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of two genes (MIP-1beta, VE-CADHERIN) implicated in acute rejection in human heart transplantation: use of murine models in tandem with cDNA arrays.
    Roussoulières AL; Raisky O; Chalabreysse L; Dureau G; Cerutti C; Thieblemont C; Boissonnat P; Sebbag L; Obadia JF; Ninet J; Bastien O; Thivolet-Bejui F; McGregor JL
    Circulation; 2005 May; 111(20):2636-44. PubMed ID: 15897346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival.
    Liang X; Lu L; Chen Z; Vickers T; Zhang H; Fung JJ; Qian S
    Transplantation; 2003 Aug; 76(4):721-9. PubMed ID: 12973117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival.
    Gorczynski RM; Cattral MS; Chen Z; Hu J; Lei J; Min WP; Yu G; Ni J
    J Immunol; 1999 Aug; 163(3):1654-60. PubMed ID: 10415071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of allograft tolerance through costimulatory blockade: first selection of drugs in vitro.
    Vierboom MP; Ossevoort M; Sick EA; Haanstra K; Jonker M
    Transpl Immunol; 2003; 11(2):215-22. PubMed ID: 12799206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft vasculopathy and tolerance: does the balance of Th cells contribute to graft vasculopathy?
    Hamano K; Bashuda H; Ito H; Shirasawa B; Okumura K; Esato K
    J Surg Res; 2000 Sep; 93(1):28-34. PubMed ID: 10945940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of CD80 and CD86 at the time of implantation inhibits maternal rejection to the allogeneic fetus in abortion-prone matings.
    Jin LP; Zhou YH; Wang MY; Zhu XY; Li DJ
    J Reprod Immunol; 2005 Apr; 65(2):133-46. PubMed ID: 15811518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anergic cells induced by the blockade of CD40-CD154 and CD28-B7 costimulatory pathways act as potent immunoregulatory cells in vitro and vivo.
    Cai Y; Zhou PJ; Tang XD
    Chin Med J (Engl); 2004 Aug; 117(8):1178-83. PubMed ID: 15361291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct requirements for host CD80/CD86 costimulatory molecules in cardiac versus islet rejection.
    Johnson Z; Beilke J; Pietra B; Kelly B; Gill RG
    Transplant Proc; 2004 May; 36(4):1171-2. PubMed ID: 15194405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy using adenoviral vector encoding 4-1BBIg gene significantly prolonged murine cardiac allograft survival.
    Huang BJ; Yin H; Huang YF; Xu JF; Xiong P; Feng W; Zheng F; Xu Y; Fang M; Gong FL
    Transpl Immunol; 2006 Aug; 16(2):88-94. PubMed ID: 16860710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of CD86 signaling facilitates a Th2 bias at the maternal-fetal interface and expands peripheral CD4+CD25+ regulatory T cells to rescue abortion-prone fetuses.
    Zhu XY; Zhou YH; Wang MY; Jin LP; Yuan MM; Li DJ
    Biol Reprod; 2005 Feb; 72(2):338-45. PubMed ID: 15456701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of tolerated and rejected islet grafts: a gene expression study.
    Berg T; Wu T; Levay-Young B; Heuss N; Pan Y; Kirchhof N; Sutherland DE; Hering BJ; Guo Z
    Cell Transplant; 2004; 13(6):619-29. PubMed ID: 15648732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts.
    Koga N; Suzuki J; Kosuge H; Haraguchi G; Onai Y; Futamatsu H; Maejima Y; Gotoh R; Saiki H; Tsushima F; Azuma M; Isobe M
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2057-62. PubMed ID: 15374847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.